Searching…
2026年7月2日 · Background: Chronic rhinosinusitis with nasal polyps (CRSwNP) is a predominantly type 2 inflammatory disease … 缺失: biomedicines 必须包含: biomedicines
2026年7月2日 · This prospective observational study evaluates the real-world effect of a 12-month mepolizumab treatment on …
Mepolizumab provides sustained clinical and radiologic improvement in severe type-2 CRSwNP. Baseline eosinophilia and olfactory … 缺失: biomedicines 必须包含: biomedicines
2026年5月1日 · Monoclonal antibodies (mAbs) have been effective in managing chronic rhinosinusitis with nasal polyps (CRSwNP) … 缺失: olfactory · biomedicines 必须包含: olfactory · biomedicines
2026年3月7日 · To assess the real-life efficacy and safety of mepolizumab in patients with CRSwNP, both with and without comorbid … 缺失: biomedicines 必须包含: biomedicines
Chronic rhinosinusitis with nasal polyps (CRSwNP) is a type 2 inflammation-driven condition that causes nasal blockage, olfactory … 缺失: biomedicines 必须包含: biomedicines
2026年4月6日 · Dupilumab and mepolizumab improved clinical outcomes in severe CRSwNP, with dupilumab offering greater benefit … 缺失: biomedicines 必须包含: biomedicines
Olfactory testing is often underrepresented in the literature, with the majority of studies either omitting olfactometry assessments or … 缺失: biomedicines 必须包含: biomedicines
2026年2月13日 · Using machine learning to identify clinical biomarkers for determining optimal response to mepolizumab in chronic … 缺失: olfactory 必须包含: olfactory
2026年3月28日 · We aimed to synthesize current evidence on the smell-restoring efficacy of biologics, focusing on outcomes …
